Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-48,088
Closed -$1.11M 181
2024
Q4
$1.11M Sell
48,088
-1,803,937
-97% -$51.8M 0.37% 83
2024
Q3
$53.2K Buy
1,852,025
+1,798,427
+3,355% +$61.4M 0.02% 185
2024
Q2
$1.73M Buy
53,598
+196
+0.4% +$6.53K 0.62% 55
2024
Q1
$1.81M Buy
53,402
+7,193
+16% +$274K 0.65% 53
2023
Q4
$1.82M Sell
46,209
-1,728
-4% -$66.9K 0.69% 50
2023
Q3
$1.83M Buy
+47,937
New +$2.01M 0.76% 45
2023
Q1
$1.94M Buy
43,363
+5,120
+13% +$231K 0.78% 46
2022
Q4
$1.68M Buy
+38,243
New +$1.72M 0.68% 54

Other funds holding BCE

Pathway Financial Advisers's BCE Position: Q1 2025 in Review

Pathway Financial Advisers sold out of BCE (BCE) in Q1 2025, closing a stake of 48,088 shares — an estimated $1.11M sold.

Pathway Financial Advisers first reported a position in BCE in Q4 2022 and held it in 8 quarters. The position peaked at $1.94M in Q1 2023. 401 funds tracked by Wall St. Rank hold BCE as of Q1 2025.

  • Pathway Financial Advisers reported no remaining BCE position as of Q1 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 48,088 BCE shares in Q1 2025, an estimated $1.11M.
  • Pathway Financial Advisers first reported a position in BCE in Q4 2022 and held it in 8 quarters.
  • Pathway Financial Advisers's BCE position peaked at $1.94M in Q1 2023.
  • 401 funds tracked by Wall St. Rank held BCE as of Q1 2025.

Based on Pathway Financial Advisers's 13F filing for Q1 2025, filed 9 May 2025.